Skip to main content
. 2017 May 29;41(6):891–901. doi: 10.1007/s10608-017-9862-9

Fig. 3.

Fig. 3

Scores on secondary outcomes scales at end-of-baseline, post-treatment and follow-up for each patient. FCRI Fear of Cancer Recurrence Inventory, HADS Hospital Anxiety and Depression Scale, MCQ-30 Metacognitions Questionnaire-30